May 14, 2018 / 12:42 PM / 2 months ago

BRIEF-Zosano Reaches Enrollment Milestone In M207-Adam Long-Term Safety Study

May 14 (Reuters) - Zosano Pharma Corp:

* ZOSANO REACHES ANOTHER ENROLLMENT MILESTONE IN M207-ADAM LONG-TERM SAFETY STUDY

* ZOSANO PHARMA CORP -M207-ADAM LONG-TERM SAFETY STUDY IS ON TRACK TO HAVE MORE THAN 50 SUBJECTS COMPLETE ONE YEAR OF EVALUATION BY END OF MARCH 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below